SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-16-759083
Filing Date
2016-11-03
Accepted
2016-11-03 17:24:54
Documents
3
Group Members
ALAN FRAZIERFHM V, L.L.C.FHM V, L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d287065dsc13da.htm SC 13D/A 22551
2 EXHIBIT 1 d287065dex991.htm EX-99.1 10287
3 EXHIBIT 2 d287065dex992.htm EX-99.2 5634
  Complete submission text file 0001193125-16-759083.txt   40386
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87592 | Film No.: 161972868
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 (206) 621-7200
Frazier Healthcare V, LP (Filed by) CIK: 0001341169 (see all company filings)

IRS No.: 830410164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A